Skip to main content

Peer Review reports

From: Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report

Original Submission
15 Nov 2023 Submitted Original manuscript
29 Nov 2023 Reviewed Reviewer Report - Hiroko Bando
12 Dec 2023 Reviewed Reviewer Report - Mihai Marinca
1 Jan 2024 Reviewed Reviewer Report - Ho Gwo Fuang
4 Jan 2024 Reviewed Reviewer Report - Ciniraj Raveendran
9 Jan 2024 Reviewed Reviewer Report - luigi cavanna
14 Jan 2024 Author responded Author comments - Keiko Inakami
Resubmission - Version 2
14 Jan 2024 Submitted Manuscript version 2
21 Jan 2024 Reviewed Reviewer Report - Ciniraj Raveendran
23 Jan 2024 Reviewed Reviewer Report - Mihai Marinca
9 Mar 2024 Author responded Author comments - Keiko Inakami
Resubmission - Version 3
9 Mar 2024 Submitted Manuscript version 3
Publishing
24 Mar 2024 Editorially accepted
1 May 2024 Article published 10.1186/s13256-024-04522-2

You can find further information about peer review here.

Back to article page